In experiments in vitro, the percentage of ILC2s in peripheral blood from patients with allergic asthma was significantly greater and responsive to IL-33 and IL-25, leading to the production of higher levels of IL-5 and IL-13 than healthy controls [17,18]. The gene discussed is IL33; the disease is allergic asthma.